• Info
  • Insider Ownership

Insider Trading & Ownership of Kathryn E. Falberg

Location
Ventura, CA
Summary
The estimated net worth of Kathryn E. Falberg is at least $1,386,132 dollars as of 25 Mar 2026. Kathryn E. Falberg is the Director of Arcus Biosciences, Inc. and owns shares of Arcus Biosciences, Inc. (RCUS) stock worth about $1.39M.
Signature
/s/ Kelli Faerber, Attorney-in-Fact for Kathryn E. Falberg
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Kathryn E. Falberg and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Sign up to save research and follow filings

Quick Takeaways

  • Kathryn E. Falberg has 5 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $1,386,132.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Arcus Biosciences, Inc. ($1,386,132).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Kathryn E. Falberg

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RCUS Arcus Biosciences, Inc. Director $1,386,132 10 Jun 2025
TTD Trade Desk, Inc. Director $0 -$4,655,113 -100% 23 Mar 2026
NUVB Nuvation Bio Inc. Director 21 May 2025
TCDA Tricida, Inc. Director 15 Jun 2022
URGN UroGen Pharma Ltd. Director 07 Jun 2021

Insider Transactions Reported by Kathryn E. Falberg:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.